Form 4 for PCVX Vaxcyte, Inc.
Accepted 2026-01-16 00:00:00 ET · period of report 2026-01-14 · accession 0001230724-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-01-16 | 2026-01-14 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | G - Gift | $0.00 | +61.9K | 61.9K | New | $0 |
| 2026-01-16 | 2026-01-14 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | G - Gift | $0.00 | -61.9K | 62.5K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-14 | G | A | 61,850 | $0.00 | 61,850 | I See Footnote | — | — | (F2) Shares are held by ALG 2025 GRAT HOLDINGS LLC, of which 100% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person is the sole annuitant and trustee. |
| 2 | Common | Common Stock | 2026-01-14 | G | D | 61,850 | $0.00 | 62,459 | D | — | — | (F1) The reported transaction involves the Reporting Person's transfer of shares to ALG 2025 GRAT HOLDINGS LLC, of which Reporting Person is the sole member and manager. |